⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Novo Nordisk announces more than 400 million euro expansion in its manufacturing facility in Athlone, Ireland
globenewswire.com
NVO
Studies explore: GLP-1 receptor agonist use and its impact on long-term musculoskeletal health and orthopaedic surgical outcomes
prnewswire.com
NVO
LLY
Bronstein, Gewirtz & Grossman, LLC Encourages Novo Nordisk A/S (NVO) Stockholders to Inquire about Securities Investigation
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications
prnewswire.com
NVO
Bronstein, Gewirtz & Grossman, LLC Encourages Novo Nordisk A/S (NVO) Investors to Inquire about Securities Investigation
accessnewswire.com
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
accessnewswire.com
NVO
SkinnyRx GLP-1 Weight Loss 2026: Compounded Semaglutide and Tirzepatide Program, Pricing, and FDA Regulatory Status Examined
globenewswire.com
ELAN
LLY
NVO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
prnewswire.com
NVO